REFERENCES
1 Wang, C., Horby, P. W., Hayden, F. G. & Gao, G. F. A novel
coronavirus outbreak of global health concern. The Lancet395 , 470-473 (2020).
2 Saberiyan, M. et al. An Overview on the Common Laboratory
Parameter Alterations and their Related Molecular Pathways in Screening
for COVID-19 Patients. Clinical laboratory 66 (2020).
3 Tuite, A. R. et al. Estimation of coronavirus disease 2019
(COVID-19) burden and potential for international dissemination of
infection from Iran. Annals of Internal Medicine 172 ,
699-701 (2020).
4 Oei, W. & Nishiura, H. The relationship between tuberculosis and
influenza death during the influenza (H1N1) pandemic from 1918-19.Computational and Mathematical Methods in Medicine 2012(2012).
5 Walaza, S. et al. Excess mortality associated with influenza
among tuberculosis deaths in South Africa, 1999–2009. PloS one10 , e0129173 (2015).
6 Zürcher, K. et al. Influenza pandemics and tuberculosis
mortality in 1889 and 1918: analysis of historical data from
Switzerland. PLoS One 11 , e0162575 (2016).
7 Wong, C.-Y. et al. Tuberculosis in a SARS outbreak. J
Chin Med Assoc 67 , 579-582 (2004).
8 Liu, W. et al. Pulmonary tuberculosis and SARS, China. (2006).
9 Alfaraj, S. H., Al-Tawfiq, J. A., Altuwaijri, T. A. & Memish, Z. A.
Middle East respiratory syndrome coronavirus and pulmonary tuberculosis
coinfection: implications for infection control. Intervirology60 , 53-55 (2017).
10 Jain, V. K., Iyengar, K. P., Samy, D. A. & Vaishya, R. Tuberculosis
in the era of COVID-19 in India. Diabetes & Metabolic Syndrome:
Clinical Research & Reviews 14 , 1439-1443 (2020).
11 Corman, V. M. et al. Detection of 2019 novel coronavirus
(2019-nCoV) by real-time RT-PCR. Eurosurveillance 25 ,
2000045 (2020).
12 Nalla, A. K. et al. Comparative performance of SARS-CoV-2
detection assays using seven different primer-probe sets and one assay
kit. Journal of clinical microbiology 58 (2020).
13 Jiang, F.-C. et al. Detection of severe acute respiratory
syndrome coronavirus 2 RNA on surfaces in quarantine rooms.Emerging Infectious Diseases 26 , 2162 (2020).
14 Patel, A. & Jernigan, D. B. Initial public health response and
interim clinical guidance for the 2019 novel coronavirus
outbreak—United States, December 31, 2019–February 4, 2020.Morbidity and Mortality Weekly Report 69 , 140 (2020).
15 Singh, A., Prasad, R., Gupta, A., Das, K. & Gupta, N. Severe acute
respiratory syndrome coronavirus-2 and pulmonary tuberculosis:
convergence can be fatal. Monaldi Archives for Chest Disease90 (2020).
16 Pathak, L. et al. Coronavirus activates a stem cell-mediated
defense mechanism that reactivates dormant tuberculosis: implications in
COVID-19 pandemic. bioRxiv (2020).
17 Tadolini, M. et al. Active tuberculosis, sequelae and COVID-19
co-infection: first cohort of 49 cases. European Respiratory
Journal (2020).
18 Stochino, C. et al. Clinical characteristics of COVID-19 and
active tuberculosis co-infection in an Italian reference hospital.European Respiratory Journal (2020).
19 Liu, Y. et al. Active or latent tuberculosis increases
susceptibility to COVID-19 and disease severity. Medrxiv (2020).